Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BQ.1.15ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.15ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.15NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CA.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CA.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CA.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CA.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CP.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CP.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CP.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CP.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.3.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.3.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.3.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.3.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
ED.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
ED.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
ED.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
ED.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CM.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CM.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CM.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CM.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-18073.5US
CA.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CA.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CA.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CA.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BN.1.9ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BN.1.9ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BN.1.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.1.9NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.28ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.28ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.28ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.28NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
DG.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
DG.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DG.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DG.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.2.56ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.2.56ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.56ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.56NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KP.2.13ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KP.2.13ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KP.2.13ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used